Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effective Adjunctive Use of Pergolide With Risperidone for Cognitive Impairment and Negative Symptoms in Schizophrenia

NCT00197483 is registered in ClinicalTrials.gov with Hamamatsu University as lead sponsor.

NCT NCT00197483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00197483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effective Adjunctive Use of Pergolide With Risperidone for Cognitive Impairment and Negative Symptoms in Schizophrenia
Lead sponsor
Hamamatsu University
Phase
Observational
Overall status
Suspended
Start date
March 31, 2003
Completion date
Not reported
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairments, negative symptoms, schizophrenia